Northern Trust’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-87,153
| Closed | -$37.9K | – | 4654 |
|
|
2022
Q4 | $37.9K | Hold |
87,153
| – | – | ﹤0.01% | 4350 |
|
|
2022
Q3 | $24K | Hold |
87,153
| – | – | ﹤0.01% | 4521 |
|
|
2022
Q2 | $31K | Hold |
87,153
| – | – | ﹤0.01% | 4550 |
|
|
2022
Q1 | $58K | Hold |
87,153
| – | – | ﹤0.01% | 4504 |
|
|
2021
Q4 | $112K | Hold |
87,153
| – | – | ﹤0.01% | 4387 |
|
|
2021
Q3 | $189K | Sell |
87,153
-34,510
| -28% | -$74.8K | ﹤0.01% | 4209 |
|
|
2021
Q2 | $333K | Buy |
+121,663
| New | +$333K | ﹤0.01% | 3888 |
|
|
2018
Q2 | – | Sell |
-41,792
| Closed | -$445K | – | 4343 |
|
|
2018
Q1 | $445K | Sell |
41,792
-93
| -0.2% | -$990 | ﹤0.01% | 3604 |
|
|
2017
Q4 | $1.77M | Sell |
41,885
-790
| -2% | -$33.3K | ﹤0.01% | 3209 |
|
|
2017
Q3 | $2.35M | Buy |
42,675
+2,339
| +6% | +$129K | ﹤0.01% | 3074 |
|
|
2017
Q2 | $7.48M | Buy |
40,336
+6,542
| +19% | +$1.21M | ﹤0.01% | 2354 |
|
|
2017
Q1 | $4.04M | Buy |
33,794
+4,923
| +17% | +$588K | ﹤0.01% | 2687 |
|
|
2016
Q4 | $2.87M | Buy |
28,871
+906
| +3% | +$90K | ﹤0.01% | 2890 |
|
|
2016
Q3 | $3.13M | Buy |
27,965
+10,591
| +61% | +$1.19M | ﹤0.01% | 2817 |
|
|
2016
Q2 | $1.78M | Buy |
17,374
+833
| +5% | +$85.5K | ﹤0.01% | 3105 |
|
|
2016
Q1 | $1.52M | Buy |
16,541
+49
| +0.3% | +$4.5K | ﹤0.01% | 3105 |
|
|
2015
Q4 | $2.38M | Buy |
16,492
+14,948
| +968% | +$2.16M | ﹤0.01% | 2958 |
|
|
2015
Q3 | $160K | Buy |
+1,544
| New | +$160K | ﹤0.01% | 3812 |
|